|
Biodelivery Sciences International Inc (BDSI) |
|
|
|
Biodelivery Sciences International Inc 's Revenue per Employee
Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales
With a revenue increase of 2.33% in the forth quarter 2021, year on year to cumulative value of $167 million, Biodelivery Sciences International Inc 's revenue per employee grew on a trailing twelve months basis to $ 1,389,192, this marks a new company high. Within the Healthcare sector Employees of 37 other companies have achieved higher revenue per employee. While Biodelivery Sciences International Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 478. Biodelivery Sciences International Inc has 120 employees.
What is Sales per Employee Ratio?
Select the Comparisons :
|
|
Select the Ratio:
|
|
BDSI Revenue per Employee |
(Dec 31 2021) IV. Quarter |
(Sep 30 2021) III. Quarter |
(Jun 30 2021) II. Quarter |
(Mar 31 2021) I. Quarter |
(Dec 31 2020) IV. Quarter |
Y / Y Revenue Change |
2.33 % |
4.18 % |
13.28 % |
7.16 % |
33.29 % |
Sales per Employee
(TTM) $ |
1,389,192 |
1,380,992 |
1,367,250 |
1,326,775 |
1,303,925 |
BDSI's Total
Ranking |
# 478 |
# 0 |
# 0 |
# 0 |
# 0 |
Seq. Revenue Change |
5.01 % |
-0.84 % |
1.02 % |
-2.72 % |
6.91 % |
Revenue per Employee Statistics |
High |
Average |
Low |
$ 1,389,192 |
$ 620,913 |
$ 94,632 |
(Dec 31 2021) |
|
(Dec. 30, 2013) |
Date modified: 2023-03-23T19:06:47+00:00
Companies with similar Revenue per Employee for 12 months ending Dec 31 2021, within Healthcare Sector | Revenue per Employee | Revenue 12 months ending Dec 31 2021 | Number of Employees Dec 31 2021 | Vertex Pharmaceuticals Inc | 1,942,153.85 | $ 7,574.400 Million | 3,900 | Gilead Sciences Inc | 1,896,180.56 | $ 27,305.000 Million | 14,400 | Regeneron Pharmaceuticals Inc | 1,550,125.39 | $ 16,071.700 Million | 10,368 | Bristol myers Squibb Company | 1,440,527.95 | $ 46,385.000 Million | 32,200 | Incyte Corporation | 1,426,106.49 | $ 2,986.267 Million | 2,094 | Biolife Solutions Inc | 1,156,854.37 | $ 119.156 Million | 103 | Biogen Inc | 1,142,736.73 | $ 10,981.700 Million | 9,610 | Abbvie inc | 1,123,940.00 | $ 56,197.000 Million | 50,000 | Amgen Inc | 1,073,512.40 | $ 25,979.000 Million | 24,200 | Pfizer Inc | 1,028,962.03 | $ 81,288.000 Million | 79,000 | Patterson Companies Inc | 917,489.43 | $ 6,422.426 Million | 7,000 | Enanta Pharmaceuticals Inc | 830,169.64 | $ 92.979 Million | 112 | Eli Lilly And Company | 809,097.14 | $ 28,318.400 Million | 35,000 | Mereo Biopharma Group Plc | 792,695.65 | $ 36.464 Million | 46 | Shockwave Medical Inc | 790,486.67 | $ 237.146 Million | 300 | Ptc Therapeutics inc | 769,418.57 | $ 538.593 Million | 700 | Hologic Inc | 740,048.96 | $ 5,138.900 Million | 6,944 | Elanco Animal Health Inc | 727,480.92 | $ 4,765.000 Million | 6,550 | Merck and Co Inc | 716,235.29 | $ 48,704.000 Million | 68,000 |
|